Ann: ***ong and Kochang JV Sale Update, page-11

Completely agree, assays will be the catalyst here. TMR announced decent hits this morning, and is up some 30%. Similar market cap to SAU too.

I wouldn't say the sale of our jv asset is a sideshow though. A$13m was the determined value, which is very sizeable for a company of our size.
Granted, we don't need the cash, but could it be returned to shareholders as a special dividend if we receive it all in cash?
Alternatively, McNeilly might be able to identify a cash strapped company that requires funding, in exchange for an NSR? We know that SAU's model for its own projects isn't to take them to production.

BMV might not be happy with the determined valuation for the jv assets, but they are bound by this in the agreement. Cough up, or SAU should enforce their legal rights. If the projects are going to take a long time to get to production as stated by Simon, then grow a pair and tell them to pay up. He'll, time to be the power-top for a change..